[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342079-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342079-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","atypical-chemokine-receptor-2-expression-is-directly-regulated-by-hypoxia-inducible-factor-1-alpha-in-cancer-cells-under-hypoxia","Atypical chemokine receptor 2 expression is directly regulated by hypoxia inducible factor-1 alpha in cancer cells under hypoxia","","Immune checkpoint therapies often fail because cytotoxic immune cells do not infiltrate the tumor microenvironment effectively. This study examines how hypoxia controls Atypical Chemokine Receptor 2 (ACKR2), a regulator of pro-inflammatory chemokines that promote immune cell recruitment. In silico and cell-based results identify hypoxia response element motifs in ACKR2 promoters, show HIF-1α-dependent ACKR2 overexpression, and demonstrate direct promoter regulation via chromatin immunoprecipitation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/atypical-chemokine-receptor-2-expression-is-directly-regulated-by-hypoxia-inducible-factor-1-alpha-in-cancer-cells-under-hypoxia/342079/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/atypical-chemokine-receptor-2-expression-is-directly-regulated-by-hypoxia-inducible-factor-1-alpha-in-cancer-cells-under-hypoxia/342079.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does hypoxia hinder immune cell infiltration into tumors?","Question",{"text":63,"@type":64},"Hypoxia supports an immunosuppressive tumor microenvironment and affects the chemokine network that controls immune trafficking into tumors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is ACKR2 regulated under hypoxic conditions?",{"text":68,"@type":64},"ACKR2 expression is driven by hypoxia response element motifs in its promoters and occurs in an HIF-1α-dependent manner.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports direct regulation of ACKR2 by HIF-1α?",{"text":72,"@type":64},"Chromatin immunoprecipitation data confirm HIF-1α directly binds the ACKR2 promoter in B16-F10 melanoma cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342079,1790121598,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":116,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nAtypical chemokine receptor 2 expression is directly regulated by hypoxia inducible factor-1 alpha in cancer cells under hypoxia  \nAlice Benoit1, Audrey Lequeux1, Phillip Harter1, Guy Berchem1,2,3 & Bassam Janji1􀀍  \nLack of significant and durable clinical benefit from anti-cancer immunotherapies is partly due to the failure of cytotoxic immune cells to infiltrate the tumor microenvironment. Immune infiltration is predominantly dependent on the chemokine network, which is regulated in part by chemokine and atypical chemokine receptors. We investigated the impact of hypoxia in the regulation of Atypical Chemokine Receptor 2 (ACKR2), which subsequently regulates major pro-inflammatory chemokines reported to drive cytotoxic immune cells into the tumor microenvironment. Our in silico analysis showed that both murine and human ACKR2 promoters contain hypoxia response element (HRE) motifs. Murine and human colorectal, melanoma, and breast cancer cells overexpressed ACKR2 under hypoxic conditions in a HIF-1α dependent manner; as such overexpression was abrogated in melanoma cells expressing non-functional deleted HIF-1α. We also showed that decreased expression of ACKR2 in HIF-1α-deleted cells under hypoxia was associated with increased CCL5 levels. Chromatin immunoprecipitation data confirmed that ACKR2 is directly regulated by HIF-1α at its promoter in B16-F10 melanoma cells. This study provides new key elements on how hypoxia can impair immune infiltration in the tumor microenvironment.  \nKeywords Atypical chemokine receptors, Cancer, Hypoxia, Immune infiltration, Chemokines  \nHypoxia is a well-known hallmark of solid tumors. Healthy tissues average about 5% oxygen, while hypoxic tumor tissues can exhibit a wide range of oxygen levels, which are often below 2%1. The response to hypoxic tumor microenvironment (TME) is mediated by the hypoxia-inducible factors (HIF), in particular HIF-1 alpha (HIF-1α), which promote an immunosuppressive TME and tumor immune escape2. In normoxia, HIF-1α is hydroxylated and bound to the von Hippel-Lindau (VHL) protein, which recruits an ubiquitine ligase that targets HIF-1α for degradation by the proteasome3. In hypoxia, HIF-1α is no longer hydroxylated and no longer degraded; instead, stabilized HIF-1α is translocated into the nucleus, where it can form a heterodimer with HIF- 1β/Aryl hydrocarbon Receptor Nuclear Translocator4. The heterodimer HIF-1α/HIF-1β can bind on hypoxia response elements (HRE) defined by the binding site 5’-RCGTG-3’, where R can be A or G, and activate the transcription of target genes involved in cancer progression5.  \nHypoxia also drives resistance to cancer therapies, such as chemotherapy6, radiotherapy7and immunotherapy8. Regarding the latter, it has been shown that hypoxic conditions create an immunosuppressive environment by multiple mechanisms; one of them is by decreasing the ratio of anti-tumor effector immune cells such as dendritic cells, CD4 +and CD8 +T cells, and Natural Killer (NK) cells9, relative to immunosuppressive cells such as myeloid-derived suppressor cells, tumor-associated macrophages with a pro-tumoral M2 phenotype and T-regulatory cells10. Trafficking of these critical immune cells is also mediated by chemokines and their corresponding chemokine receptors11. Studies have shown that hypoxia can impair immune cells trafficking and promote cancer progression by regulating chemokines and chemokines receptors. Indeed, in several cancer types, HIF-1 and HIF-2-mediated hypoxia can directly regulate the CC chemokines CCL2, CCL3, CCL5, CCL15, CCL16, CCL20 and CCL28, the CXC chemokines CXCL1, CXCL2, CXCL4, CXCL5, CXCL6, CXCL10, CXCL12, CXCL13, CXCL14 and CXCL16 ; as well as the chemokines receptors CCR1, CCR2, CCR5, CCR6, CCR7, CXCR1, CXCR2, CXCR4, CXCR5 and CXCR6, due to the presence of HRE on their promoters12, 13.  \n1Tumor Immunotherapy and Microenvironment (TIME) Group, Departme","cbCaihwdPFesI2TG","https://ap.wps.com/l/cbCaihwdPFesI2TG","pdf",3320760,"English","# Background\n## Hypoxia and HIF-1α signaling\n## Hypoxia-driven chemokine regulation\n## Atypical chemokine receptors (ACKRs)\n# Study focus and findings","[{\"question\":\"Why does hypoxia hinder immune cell infiltration into tumors?\",\"answer\":\"Hypoxia supports an immunosuppressive tumor microenvironment and affects the chemokine network that controls immune trafficking into tumors.\"},{\"question\":\"How is ACKR2 regulated under hypoxic conditions?\",\"answer\":\"ACKR2 expression is driven by hypoxia response element motifs in its promoters and occurs in an HIF-1α-dependent manner.\"},{\"question\":\"What evidence supports direct regulation of ACKR2 by HIF-1α?\",\"answer\":\"Chromatin immunoprecipitation data confirm HIF-1α directly binds the ACKR2 promoter in B16-F10 melanoma cells.\"}]","Atypical chemokine receptor 2 expression is directly regulated by hypoxia inducible factor-1 alpha in cancer cells under hypoxia | PDF",1790045081,23,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d52b0dedbc8b16e40f8e601b3b873f30.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e719efd4d1ada8bf25bf171990559625.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0cdeb98abb30841df575daff5c857ad.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d609b79826e5c6d12743f1b228c1412a.webp",980,1287]